Nanox Vision

Cardiovascular disease is the leading cause of death worldwide.  Nanox.AI’s Cardiac Solution detects coronary artery calcification to identify patients at risk of CAD.    Early detection can save lives. Discover how our AI-powered solution is transforming cardiac care:  https://lnkd.in/ee8i5-z9    #WorldHeartDay #HeartHealth #AIinHealthcare #CardiovascularDiseasePrevention #MedicalInnovation 

Chad, a landlocked Central African country, has faced severe challenges from climate change, with record flooding in 2022 displacing thousands and straining its fragile healthcare system. Over 6 million people face food insecurity, and healthcare access is limited, especially in rural areas. Last week, we had the privilege of hosting representatives from the Chad Embassy in response to their request for support. We showcased Nanox.ARC, an affordable imaging solution, alongside the Nanox.CONNECT, showcasing its ultra-portability to suit their specific requirements. We are delighted to explore potential opportunities to provide healthcare solutions to Chad. Learn more about Nanox’s solutions here: https://www.nanox.vision/

Today, we proudly rang the closing bell at Nasdaq to celebrate the four-year anniversary of Nanox’s IPO from this past August, and our continued growth in the medical imaging technology sector.      "We are honored to have the opportunity to commemorate our success as a publicly traded company following our four-year anniversary this past August and recent analyst day earlier today in New York City," said Erez Meltzer, CEO of Nanox. "Today, we celebrate the collective efforts of the Nanox team and the strong foundation we have built for continued growth, patient and provider satisfaction, and value creation for our shareholders.”  https://lnkd.in/ekh7A4Ex    #Nanox #Nasdaq #MedTech #Innovation #ClosingBell

🤝 Together for better health. 🔍 Nanox Vision develops imaging systems that are affordable and portable by orders of magnitude. Their goal? To drive early detection healthcare as a standard of care. 🎊 Congrats on four years of being #NasdaqListed, $NNOX!

On Friday, our team hosted an Analyst Day, presenting recent advancements and future plans. We proudly introduced our next product - Nanox.ARC X, the next version of our 3D multi-source digital tomosynthesis system featuring expanded capabilities, which is not yet regulatorily approved. The event also featured key highlights from our clinical trials. The presentation is available on our website.   We extend our sincere gratitude to everyone who participated in this event. Your engagement and support continue to drive our innovation forward in medical imaging technology.   #Nanox #MedicalImaging #HealthTech #Innovation

Today, Nanox will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Erez Meltzer, Chief Executive Officer and acting Chairman, will ring the Closing Bell. Friday, September 20, 2024 – 3:45 p.m. to 4:00 p.m. ET                    https://lnkd.in/ey5BgdZu

Some fractures can be missed on conventional X-rays, especially in areas of complex anatomic structure such as the wrist or ankle. The cast obscures some of the anatomy, and in many cases the patient is asked to remove the cast before the imaging creating discomfort for the patient. These fractures can be seen more clearly when captured through digital tomosynthesis, and the effect of the cast is minimal - hence it is unnecessary to remove the cast.    Learn more about how Nanox.ARC can improve your imaging results: https://lnkd.in/ecXjXF7r